Role of Transrectal-ultrasound in Evaluation of Azoospermia
1 other identifier
interventional
50
0 countries
N/A
Brief Summary
Azoospermia is a word meaning to ejaculates with no spermatozoa without a definite underlying cause .1% of men has azoospermia, representing nearly 10 to 15% of all infertile men. The azoospermia is a major concern in our community. There is no actual epidemiological studies to estimate the actual numbers in Egypt. Azoospermia has several classifications, pre-testicular, testicular \& post-testicular cause .The semen analysis is the main investigation done for these patient .The treatment methods range from hormonal therapy to surgery or ICSI . The imaging modalities has developed greatly in the last 3 decades. That it became in several setting as a bedside test or investigation. The main modalities used in azoospermia are scrotal ultrasound, TRUS and MRI. The first TRUS was introduced 1957.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2021
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 4, 2021
CompletedFirst Posted
Study publicly available on registry
August 30, 2021
CompletedStudy Start
First participant enrolled
October 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 5, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 5, 2022
CompletedAugust 30, 2021
August 1, 2021
1.2 years
August 4, 2021
August 23, 2021
Conditions
Outcome Measures
Primary Outcomes (4)
Number of patients With obstructive azoospermia
through study completion ,within average one year.
Number of patient with non obstructive azoospermia
through study completion , within average one year.
Number of patient that will respond to endoscopic treatment
6 month duration
Number of patients that will need sperm extraction
9 month duration
Study Arms (1)
azoospermic patients
OTHERInterventions
we perform trus to identify the cause of azospermia and its type either obstructive or not
Eligibility Criteria
You may qualify if:
- Adult patients with azoospermia as identified by semen analysis.
- Age from 18 years to more
You may not qualify if:
- History of operative intervention in the lower urinary tract.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (4)
Aziz N. The importance of semen analysis in the context of azoospermia. Clinics (Sao Paulo). 2013;68 Suppl 1(Suppl 1):35-8. doi: 10.6061/clinics/2013(sup01)05.
PMID: 23503953BACKGROUNDGudeloglu A, Parekattil SJ. Update in the evaluation of the azoospermic male. Clinics (Sao Paulo). 2013;68 Suppl 1(Suppl 1):27-34. doi: 10.6061/clinics/2013(sup01)04.
PMID: 23503952BACKGROUNDCocuzza M, Alvarenga C, Pagani R. The epidemiology and etiology of azoospermia. Clinics (Sao Paulo). 2013;68 Suppl 1(Suppl 1):15-26. doi: 10.6061/clinics/2013(sup01)03.
PMID: 23503951BACKGROUNDSihag P, Tandon A, Pal R, Jain BK, Bhatt S, Kaur S, Sinha A. Sonography in male infertility: a look beyond the obvious. J Ultrasound. 2018 Sep;21(3):265-276. doi: 10.1007/s40477-018-0294-5. Epub 2018 Mar 28.
PMID: 29594932BACKGROUND
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- resident of urology
Study Record Dates
First Submitted
August 4, 2021
First Posted
August 30, 2021
Study Start
October 5, 2021
Primary Completion
December 5, 2022
Study Completion
December 5, 2022
Last Updated
August 30, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share